Skip to content
Menu

Leerink Partners Maintains Outperform on Replimune Group, Raises Price Target to $31

Benzinga Newsdesk 3 weeks ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Leerink Partners analyst Daina Graybosch maintains Replimune Group (NASDAQ:REPL) with a Outperform and raises the price target from $19 to $31.

Leerink Partners analyst Daina Graybosch maintains Replimune Group (NASDAQ:REPL) with a Outperform and raises the price target from $19 to $31.

Read at benzinga.com